DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Yacyshyn BR. et al.
Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn’s disease.
Gut 2002; 51: 30-36
We do not assume any responsibility for the contents of the web pages of other providers.